<DOC>
	<DOC>NCT02001935</DOC>
	<brief_summary>The aim of this study is to determine whether common CYP1A2 and CYP2E1 gene polymorphisms effect metabolism of theophylline in chronic obstructive pulmonary disease patients.</brief_summary>
	<brief_title>Association Between CytochromeP4501A2 and CytochromeP4502E1 Gene Polymorphisms and Metabolism of Theophylline</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Aged 1875 years,COPD patients, male or female; regularly visiting our hospital; taking a sustainedrelease preparation of theophylline continuously for at least 2 weeks patients with renal or hepatic dysfunction; patients with congestive heart failure; patients with hypothyroidism or hyperthyroidism; patients currently taking drugs likely to affect theophylline metabolism or who had taken such drugs in the preceding week; patients with extreme obesity patients with very severe Chronic Obstructive Pulmonary Disease(COPD)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>theophylline</keyword>
	<keyword>CYP1A2</keyword>
	<keyword>CYP2E1</keyword>
</DOC>